InnoPharmax Inc. (4172.TWO)

TWD 17.1

(-0.87%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 46.07 Million 29.13 Million 48.05 Million 136.88 Million 84.89 Million
Cost of Revenue 28.61 Million 29.51 Million 40.64 Million 78.73 Million 50.82 Million
Gross Profit 17.45 Million -377 Thousand 7.41 Million 58.14 Million 34.06 Million
Operating Expenses 82.29 Million 93.45 Million 82.62 Million 86.57 Million 122.05 Million
Selling, General and Administrative Expenses 22.96 Million 21.5 Million 22.42 Million 24.16 Million 22.96 Million
Research and Development Expenses 59.32 Million 71.94 Million 60.19 Million 62.4 Million 86.04 Million
Other Expenses - -4.76 Million -5.88 Million -3.47 Million -
Cost and Expenses 110.91 Million 122.96 Million 123.26 Million 165.3 Million 172.87 Million
Operating Income -64.83 Million -103.42 Million -93.4 Million -41.38 Million -74.94 Million
Interest Expense 368 Thousand 257 Thousand 398 Thousand 619 Thousand 545 Thousand
Income Tax Expense - - - - -
Earnings before Tax -70.83 Million -103.18 Million -92.96 Million -43.89 Million -87.89 Million
Net Income -70.83 Million -103.18 Million -92.96 Million -43.89 Million -87.89 Million
Earnings Per Share Basic -0.76 -1.19 -1.06 -0.57 -1.22
Earnings Per Share Diluted -0.76 -1.19 -1.06 -0.57 -1.22
Weighted Average Shares Outstanding 92.71 Million 86.7 Million 87.64 Million 77.6 Million 72.14 Million
Weighted Average Shares Outstanding (Diluted) 92.71 Million 86.7 Million 87.64 Million 77.6 Million 72.14 Million
Gross Margin 0.38 -0.01 0.15 0.42 0.40
EBIT Margin -1.35 -3.26 -1.75 -0.20 -0.78
Profit Margin -1.54 -3.54 -1.93 -0.32 -1.04
EBITDA -62.12 Million -88.73 Million -69.76 Million -18.78 Million -70.17 Million
Earnings Before Tax Margin -1.41 -3.55 -1.94 -0.30 -0.88

Income Statement Charts